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Summary
Background Vision loss is an important public health issue in China, but a detailed understanding of national and 
regional trends in its prevalence and causes, which could inform health policy, has not been available. This study 
aimed to assess the prevalence, causes, and regional distribution of vision impairment and blindness in China in 1990 
and 2019.
Methods Data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 were used to estimate 
the prevalence of moderate and severe vision impairment and blindness in China and compare with other Group of 
20 (G20) countries. We used GBD methodology to systematically analyse all available demographic and epidemiological 
data at the provincial level in China. We compared the age-standardised prevalences across provinces, and the changes 
in proportion of vision loss attributable to various eye diseases in 1990 and 2019. We used two different counterfactual 
scenarios with respect to population structure and age-specific prevalence to assess the contribution of population 
growth and ageing to trends in vision loss.
Findings In 2019, the age-standardised prevalence was 2·57% (uncertainty interval [UI] 2·28–2·86) for moderate 
vision impairment, 0·25% (0·22–0·29) for severe vision impairment, and 0·48% (0·43–0·54) for blindness in 
China, which were all below the global average, but the prevalence of moderate and severe vision impairment had 
increased more rapidly than in other G20 countries from 1990 to 2019. The prevalence of vision loss increased with 
age, and the main causes of vision loss varied across age groups. The leading causes of vision impairment in China 
were uncorrected refractive error, cataract, and macular degeneration in both 1990 and 2019 in the overall 
population. From 1990 to 2019, the number of people with moderate vision impairment increased by 133·67% 
(from 19·65 to 45·92 million), those with severe vision impairment increased by 147·14% (from 1·89 to 4·67 million), 
and those with blindness increased by 64·35% (from 5·29 to 8·69 million); in each case, 20·16% of the increase 
could be explained by population growth. The contributions to these changes by population ageing were 87·22% 
for moderate vision impairment, 116·06% for severe vision impairment, and 99·22% for blindness, and the 
contributions by age-specific prevalence were 26·29% for moderate vision impairment, 10·91% for severe vision 
impairment, and –55·04% for blindness. The prevalence and specific causes of vision loss differed across provinces.
Interpretation Although a comprehensive national policy to prevent blindness is in place, public awareness of visual 
health needs improving, and reducing the prevalence of moderate and severe vision impairment should be prioritised 
in future work.
Funding China National Key Research and Development Programme and Beijing Municipal Special Funds for 
Medical Research on Public Welfare Development and Reform.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
4.0 license.
Introduction
Vision loss is an important public health and socio­
economic issue, not only affecting economic and edu­
cational opportunities,1 but also reducing quality of life2 
and increasing the risk of death.3 According to the Global 
Burden of Diseases, Injuries, and Risk Factors Study 
(GBD) 2019,4 about 41·91 million people worldwide were 
blind, 253·08 million people had moderate vision impair­
ment, and 33·78 million people had severe vision impair­
ment. Data from WHO showed that at least 2·2 billion 
people were affected by blindness and vision impairment 
around the world, of whom 1 billion had preventable 
vision impairment or impairment that had yet to 
be addressed.5 Uncorrected refractive error, cataract, 
age­related macular degeneration, glaucoma, and diabetic 
retinopathy were the leading causes of vision impairment 
globally.5
As the most populous country in the world, China has 
an enormous number of people with moderate­to­severe 
vision impairment or blindness. The years lived with 
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disability due to blindness and vision loss rank second 
out of all health impairments, next only to hearing loss. 
In the past decade, all levels of the Government in China 
have been vigorously promoting the prevention and 
treatment of blindness, establishing and continuously 
improving the management systems, technical guidance 
systems, and service systems at the national and 
provincial level. The main blinding eye diseases have 
been reported to be effectively contained.6 However, with 
population ageing and the rise in obesity and diabetes,7 
vision impairment due to age­related eye diseases, 
diabetic retinopathy, and other chronic eye dis eases could 
continue to increase.8
Previous studies have identified refractive errors and 
cataract as the leading causes of vision impairment and 
blindness in China.9–11 However, to date, a systematic 
anal ysis of the prevalence, sociodemographic distribution 
and causes of vision loss across all pro vinces of the 
country has not been available. The purpose of this 
study was to use GBD 2019 to analyse the prevalence, 
trends, causes, and regional distribution of moderate and 




We used the data from GBD 20194 to carry out this study. 
GBD 2019 comprehensively analysed the incidence and 
prevalence of 369 diseases and injuries and 3473 sequelae 
in 204 countries and territories from 1990 to 2019, using a 
unified and comparable method. Detailed description of 
the background and overview of this study can be found in 
GBD 2019.4 The relevant indicators of vision impairment 
and blindness were selected for the current analysis.
Definitions
We used definitions according to the Snellen chart for 
moderate vision impairment (presenting visual acuity 
[PVA] ≥6/60 and <6/18), severe vision impairment (PVA 
≥3/60 and <6/60), and blindness (PVA <3/60 or visual field 
around central fixation <10%), based on the better eye 
and measuring distant vision (apart from the explicit 
measurement of near vision loss). The diseases covered in 
this study included uncorrected refractive error, cataract, 
glaucoma, macular degeneration, diabetic retinopathy, 
trachoma, and other causes of vision impairment including 
vitamin A deficiency, retinopathy of prematurity, menin­
gitis, encephalitis, oncho cerciasis, and a residual category 
of other vision loss.
Data sources
The GBD 2019 China Study used data from national 
censuses, demo graphic surveys, disease surveillance 
point systems, and death cause registration report infor­
mation systems, and systematically reviewed the pub­
lished literature on the incidence and prevalence of 
various diseases. The current study then used the 
GBD methodology to systematically analyse all available 
demographic and epidemiological data at the provincial 
level in China, and used DisMod­MR 2.1, a Bayesian 
meta­regression tool, as the main estimation method to 
ensure consistency between incidence, prevalence, 
and mortality for each condition.4 China’s population 
censuses, done every 10 years (in 1990, 2000, and 2010), 
were the main source of demographic data by age and 
gender. In addition, data from the national population 
sample surveys conducted every 5 years were integrated, 
and a standardised methodology was used to estimate 
the population data of the other years. The annual and 
Research in context
Evidence before this study
We used the key words “vision loss”, “vision impairment”, 
“blindness”, “low vision”, “eye diseases”, “ophthalmopathy”, 
“prevalence”, and “epidemiology” to search PubMed, Science 
Direct, Web of Science, and the official websites of the Chinese 
Government and other institutions for studies and reports 
on eye diseases and vision health in China published in English 
or Chinese until Dec 31, 2019. Although many studies had 
established the prevalence and causes of vision impairment 
and blindness in China, analysis of their regional distribution 
across the country was missing. This study systematically 
analysed the prevalence, trends, and causes of vision loss in 
China and its regional distribution on the basis of the results of 
the Global Burden of Diseases, Injuries, and Risk Factors Study 
(GBD) 2019.
Added value of this study
This study comprehensively assessed vision loss in all the 
provinces across the country, and updated the prevalence 
estimates of vision impairment and blindness in China 
in 2019. The GBD 2019 China study incorporated important 
developments since 2013, including expanded data sources, 
enhanced data accuracy, and improved model estimates.
Implications of all the available evidence
Our research provides important information for planning 
of public health services through the analysis of moderate 
and severe vision impairment and blindness. We showed 
that the burden of vision loss, especially moderate and severe 
vision impairment, was heavy in China, and we emphasised 
that the overall visual health of the Chinese population, 
not only blindness, deserves attention and intervention 
efforts. In particular, actions should be taken to prevent and 
control cataracts in older people and refractive error in 
adolescents and children.
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single­year age estimates of net migration and population 
in China were generated using a Bayesian hierarchical 
cohort component model. Standard population structure 
used in age standardisation was generated using the 
estimated age structures of the population for selected 
national level population with at least 5 million in 
each group.12 By systematically pro cessing the data of 
various surveys and literature abstracts, we obtained 
the prevalence of each disease type by age group, and 
we obtained the corresponding number of patients 
according to the population and demographic com­
position of China.
Data on overall vision loss came from surveys mea s­
uring visual acuity in representative population­based 
studies, either from publications in peer­reviewed and 
grey literature or surveys for which we had the unit 
record data. We excluded studies that did not explicitly 
state that they measured acuity in both eyes. Only the 
data filtered by quality control criteria were included for 
the modelling estimation (appendix 2 pp 2–10). GBD 2019 
also added literature sources from a systematic review 
conducted by collaborators in the Vision Loss Expert 
Group (VLEG), in which all screened abstracts were sent 
to regional expert groups to assess the data quality for 
inclusion. The VLEG was composed of more than 
100 optometrists and epidemiologists specialising in 
vision loss. The VLEG was subdivided into regional 
expert groups, which then completed an in­depth review 
of articles within their area of geographical specialisation.
Data analysis
We analysed the prevalence and causes of vision loss in 
China in 1990 and 2019 and compared them with 
age­standardised prevalence of moderate vision impair­
ment, severe vision impairment, and blindness in 2019 
across the Group of 20 (G20, an international economic 
cooperation forum composed of 20 major economies, 
from which we excluded the EU from analysis and compared 
only 19 countries) and with the global average trends in 
visual impairment from 1990 to 2019, also from the GBD 
dataset. We then assessed the age­standardised preva lence 
of moderate vision impairment, severe vision impairment, 
and blindness in the Chinese provinces in 1990 and 2019, 
and the changes in the proportion of vision loss caused by 
various eye diseases from 1990 to 2019. Age­standardised 
population in the GBD was calculated using the GBD world 
population age standard.12,13
For each major disease, we estimated the changes in 
number of patients between 1990 and 2019 attributable to 
population growth, population structure, and age­specific 
prevalence.14,15 The observed change in the total number 
of patients equalled the net change of these three aspects. 
The decomposition analysis used two counterfactual 
scenarios to calculate the number of patients. The first 
scenario assumed that the total population grew as 
observed from 1990 to 2019, but that the population 
structure and age­specific prevalence were the same 
in 2019 as in 1990. In the second scenario, total population 
and population structure changed from 1990 to 2019 as 
observed, but the age­specific disease prevalences were 
the same in 2019 as in 1990. The difference between 
the number of patients observed in 1990 and the first 
scenario was the change in the number of patients 
exclusively from population growth. The difference 
between the first and the second scenario was the change 
in the number of patients exclusively attributable to 
population ageing. The difference between the second 
scenario and the number of patients observed in 2019 
was the change in the number of patients exclusively 
attributable to age­specific prevalence.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. All authors had full access to all the data in the 
study, and the corresponding author had responsibility 
for the decision to submit for publication.
Results
In 2019, the age­standardised prevalence was 2·57% 
(uncertainty interval [UI] 2·28–2·86) for moderate vision 
impairment, 0·25% (0·22–0·29) for severe vision 
impair ment, and 0·48% (0·43–0·54) for blindness in 
China, which were all lower than the global average 
(appendix 2 pp 11–12). From 1990 to 2019, the age­
standardised prevalence of moderate vision impairment 
in China increased by 12·17% (95% UI 10·78–13·46), 
which was the largest increase among the G20 countries 
and was much higher than the global average of 1·48% 
(0·95–2·07). Although the age­standardised prevalence 
of severe vision impairment in South Africa, China, and 
Australia increased, that in the other G20 countries and 
the global average decreased. With the exception of the 
USA, the age­standardised prevalence of blindness in all 
the other G20 countries declined. China had a decrease 
in the age­standardised prevalence of blindness of 
24·53% (95% UI 21·73–27·07), which was slightly lower 
than the global average of 27·14% (26·33–27·94) and 
ranked only 13th among the G20 (appendix 2 pp 11–12).
In 2019 in China, 45·92 million (95% UI 40·35–51·94) 
people had moderate vision impairment, 4·67 million 
(4·03–5·41) had severe vision impairment, and 
8·69 million (7·54–9·89) had blindness (table 1). The 
crude prevalence was 3·23% (95% UI 2·84–3·65) for 
moderate vision impairment, 0·33% (0·28–0·38) for 
severe vision impairment, and 0·61% (0·53–0·70) 
for blindness (table 1). The prevalence of moderate vision 
impairment was substantially higher than that of severe 
vision impairment and blindness (table 1).
The main causes of moderate vision impairment and 
severe vision impairment in 2019 were uncorrected 
refractive error, cataract, and macular degeneration. The 
main causes of blindness were cataract, uncorrected refrac­
tive error, and glaucoma. Compared with 1990, the leading 
For the Vision Loss Expert 
Group see https://www.
globalvisiondata.org/about.html
See Online for appendix 2
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causes of vision loss remained the same in 2019 (table 2). 
From 1990 to 2019, the proportion of people with moderate 
vision impairment caused by uncorrected refractive error 
decreased from 66·19% (13·01/19·65 million) to 51·87% 
(23·81/45·92 million), the proportion caused by macular 
degeneration increased from 3·39% (0·67/19·65 million) 
to 4·56 % (2·09/45·92 million), and the proportion 
caused by cataract increased significantly from 17·67% 
(3·47/19·65 million) to 30·15% (13·84/45·92 million). For 
severe vision impairment from 1990 to 2019, the pro portion 
caused by uncorrected refractive error decreased from 
56·00% (1·06/1·89 million) to 49·61% (2·32/4·67 million), 
that by mac ular degeneration increased from 3·36% 
(0·06/1·89 million) to 4·14% (0·19/4·67 million), and 
that by cataracts increased substantially from 19·04% 
(0·36/1·89 million) to 28·93% (1·35/4·67 million). The 
proportion of blindness caused by various diseases showed 
no marked change. It is worth noting that the number of 
people with vision loss caused by trachoma in China 
dropped substantially.
The causes of vision loss by age and sex in China in 2019 
are in the appendix (appendix 2 pp 13–14). The overall 
prevalence of vision loss in females was higher than that 
in males. The number of women older than 70 years with 
moderate vision impairment, severe vision impairment, 
and blind ness caused by cataracts was about twice as high 
as the number in men older than 70 years (appendix 2 p 14). 
The prevalence of vision loss increased with age, and the 
main causes of vision loss were different in different age 
groups. The main cause of moderate vision impairment 
in people younger than 70 years was uncorrected 
refractive error, whereas the main causes in those older 
than 70 years were cataract and uncorrected ref ractive 
error (appendix 2 p 13). For severe vision impairment, 
among children younger than 15 years, the main cause 
was what we labelled other causes; among people aged 
15–70 years it was uncorrected refractive error; and among 
people older than 70 years it was uncorrected refractive 
error and cataract (appendix 2 pp 13–14). Blindness 
among people younger than 50 years was mainly caused 
Moderate vision impairment Severe vision impairment Blindness
Prevalence, % (95% UI) Number, millions (95% UI) Prevalence, % (95% UI) Number, millions (95% UI) Prevalence, % (95% UI) Number, millions (95% UI)
All 3·23% (2·84–3·65) 45·92 (40·35–51·94) 0·33% (0·28–0·38) 4·67 (4·03–5·41) 0·61% (0·53–0·70) 8·69 (7·54–9·89)
Males 2·71% (2·38–3·07) 19·61 (17·22–22·26) 0·26% (0·23–0·30) 1·88 (1·63–2·17) 0·54% (0·47–0·62) 3·92 (3·40–4·47)
<5 years 0·58% (0·38–0·76) 0·26 (0·20–0·33) 0·06% (0·04–0·08) 0·02 (0·02–0·03) 0·10% (0·07–0·13) 0·04 (0·03–0·06)
5–14 years 0·96% (0·74–1·22) 0·75 (0·57–0·95) 0·04% (0·03–0·04) 0·03 (0·02–0·03) 0·12% (0·09–0·15) 0·10 (0·07–0·12)
15–49 years 0·81% (0·67–0·95) 3·00 (2·48–3·52) 0·06% (0·05–0·07) 0·21 (0·18–0·25) 0·23% (0·20–0·26) 0·84 (0·72–0·98)
50–69 years 4·65% (3·81–5·74) 8·57 (7·04–10·59) 0·44% (0·36–0·52) 0·81 (0·66–0·97) 0·84% (0·70–1·01) 1·54 (1·28–1·86)
≥70 years 14·30% (11·67–17·18) 7·04 (5·75–8·46) 1·64% (1·33–2·07) 0·81 (0·65–1·02) 2·83% (2·30–3·45) 1·40 (1·13–1·70)
Females 3·77% (3·31–4·26) 26·30 (23·10–29·68) 0·40% (0·35–0·46) 2·79 (2·41–3·23) 0·68% (0·59–0·78) 4·77 (4·14–5·42)
<5 years 0·62% (0·47–0·80) 0·23 (0·18–0·30) 0·04% (0·03–0·05) 0·01 (0·01–0·02) 0·07% (0·05–0·09) 0·03 (0·02–0·04)
5–14 years 1·09% (0·84–1·38) 0·71 (0·55–0·90) 0·03% (0·03–0·04) 0·02 (0·02–0·03) 0·09% (0·07–0·12) 0·06 (0·05–0·08)
15–49 years 0·99% (0·82–1·17) 3·49 (2·87–4·12) 0·07% (0·06–0·08) 0·24 (0·20–0·29) 0·21% (0·18–0·25) 0·74 (0·63–0·86)
50–69 years 5·78% (4·71–7·14) 10·65 (8·69–13·17) 0·59% (0·48–0·71) 1·09 (0·88–1·30) 0·94% (0·78–1·12) 1·73 (1·44–2·06)
≥70 years 19·11% (15·78–22·64) 11·22 (9·26–13·30) 2·42% (1·98–3·04) 1·42 (1·16–1·79) 3·77% (3·11–4·52) 2·21 (1·82–2·66)
95% UI=95% uncertainty interval.







Trachoma Other causes Total
Moderate vision impairment
1990 3·47 (17·67%) 13·01 (66·19%) 0·67 (3·39%) 0·21 (1·05%) 0·27 (1·36%) 0·09 (0·43%) 1·95 (9·90%) 19·65 (100%)
2019 13·84 (30·15%) 23·81 (51·87%) 2·09 (4·56%) 0·78 (1·70%) 0·77 (1·68%) 0·04 (0·08%) 4·58 (9·96%) 45·92 (100%)
Severe vision impairment
1990 0·36 (19·04%) 1·06 (56·00%) 0·06 (3·36%) 0·02 (1·04%) 0·03 (1·59%) 0·01 (0·46%) 0·35 (18·51%) 1·89 (100%)
2019 1·35 (28·93%) 2·32 (49·61%) 0·19 (4·14%) 0·07 (1·53%) 0·09 (1·85%) <0·01 (0·07%) 0·65 (13·88%) 4·67 (100%)
Blindness
1990 1·77 (33·57%) 0·75 (14·20%) 0·16 (2·98%) 0·36 (6·75%) 0·06 (1·21%) 0·13 (2·47%) 2·05 (38·81%) 5·29 (100%)
2019 2·95 (33·92%) 1·15 (13·19%) 0·32 (3·64%) 0·48 (5·57%) 0·23 (2·63%) 0·06 (0·69%) 3·51 (40·36%) 8·69 (100%)
Data are n (%), where n is in millions and % is proportion of total annual vision loss cases represented by each cause.
Table 2: Number (in millions) and proportion of vision loss by cause in China in 1990 and 2019
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by other causes, whereas among those older than 50 years 
it was mainly caused by cataract and other causes 
(appendix 2 p 14).
The changes in the number of people with moderate 
vision impairment, severe vision impairment, and 
blindness across disease types was, by varying degrees, 
accounted for by population growth, population ageing, 
and changes in age­specific prevalence (table 3). Popu­
lation ageing was the most important factor in the 
increase in moderate vision impairment, severe vision 
impairment, and blindness. From 1990 to 2019, the 
num ber of people with moderate vision impairment 
increased by 133·67% (from 19·65 to 45·92 million), of 
which 87·22% was due to population ageing, 26·29% was 
due to the increase in age­specific prevalence, 
and 20·16% was due to population growth (table 3). 
The number of people with severe vision impair ment 
increased by 147·14% (from 1·89 to 4·67 million), of 
which 116·06% was due to population ageing, 20·16% was 
due to population growth, and 10·91% was due to 
the increase in age­specific prevalence. The number of 
people with blindness increased by 64·35% (from 
5·29 to 8·69 million), of which 99·22% was due to popu­
lation ageing, and 20·16% was due to population growth, 
although there was a 55·04% decrease in blindness 
attri bu table to age­specific prevalence. Among the 
diseases leading to moderate vision impair ment and 
severe vision impairment, cataract and glaucoma had the 
largest increase. Except for uncorrected refractive error 
and trachoma, changes in age­specific prevalence of all 
other diseases leading to moderate vision impairment 
and severe vision impairment contributed positively to 
the increase in the number of patients. Among the 












Observed number of people in 1990 3·47 13·01 0·67 0·21 0·27 0·09 1·95 19·65
Number expected with 2019 population, 1990 population age structure, 
and 1990 prevalence
4·17 15·63 0·80 0·25 0·32 0·10 2·34 23·61
Number expected with 2019 population, 2019 population age structure, 
and 1990 prevalence
9·84 23·81 1·77 0·57 0·69 0·21 3·87 40·75
Observed number of people in 2019 13·84 23·81 2·09 0·78 0·77 0·04 4·58 45·92
Percentage change from 1990 due to population growth 20·16% 20·16% 20·16% 20·16% 20·16% 20·16% 20·16% 20·16%
Percentage change from 1990 due to population ageing 163·05% 62·86% 144·85% 156·04% 138·58% 125·37% 78·98% 87·22%
Percentage change from 1990 due to change in age-specific prevalence 115·43% 0·07% 49·00% 102·55% 30·55% –203·56% 36·03% 26·29%
Observed percentage change from 1990 to 2019 298·64% 83·09% 214·02% 278·75% 189·29% –58·03% 135·18% 133·67%
Severe vision impairment
Observed number of people in 1990 0·36 1·06 0·06 0·02 0·03 0·01 0·35 1·89
Number expected with 2019 population, 1990 population age structure, 
and 1990 prevalence
0·43 1·27 0·08 0·02 0·04 0·01 0·42 2·27
Number expected with 2019 population, 2019 population age structure, 
and 1990 prevalence
1·03 2·52 0·17 0·06 0·08 0·02 0·58 4·46
Observed number of people in 2019 1·35 2·32 0·19 0·07 0·09 <0·01 0·65 4·67
Percentage change from 1990 due to population growth 20·16% 20·16% 20·16% 20·16% 20·16% 20·16% 20·16% 20·16%
Percentage change from 1990 due to population ageing 167·24% 118·44% 150·79% 163·77% 136·86% 120·43% 45·34% 116·06%
Percentage change from 1990 due to change in age-specific prevalence 88·13% –19·69% 33·25% 80·52% 29·75% –201·73% 19·76% 10·91%
Observed percentage change from 1990 to 2019 275·53% 118·92% 204·20% 264·45% 186·78% –61·14% 85·26% 147·14%
Blindness
Observed number of people in 1990 1·77 0·75 0·16 0·36 0·06 0·13 2·05 5·29
Number expected with 2019 population, 1990 population age structure, 
and 1990 prevalence
2·13 0·90 0·19 0·43 0·08 0·16 2·47 6·35
Number expected with 2019 population, 2019 population age structure, 
and 1990 prevalence
4·60 1·45 0·42 1·00 0·15 0·32 3·67 11·60
Observed number of people in 2019 2·95 1·15 0·32 0·48 0·23 0·06 3·51 8·69
Percentage change from 1990 due to population growth 20·16% 20·16% 20·16% 20·16% 20·16% 20·16% 20·16% 20·16%
Percentage change from 1990 due to population ageing 138·77% 72·62% 146·62% 159·60% 108·82% 127·23% 58·53% 99·22%
Percentage change from 1990 due to change in age-specific prevalence –92·90% –40·19% –66·01% –144·08% 126·53% –201·64% –7·77% –55·04%
Observed percentage change from 1990 to 2019 66·04% 52·59% 100·77% 35·69% 255·51% –54·25% 70·92% 64·35%
Data are n or %, where n is in millions. Table shows both modelled values under hypothetical counterfactual scenarios and actual values observed in the real world.
Table 3: Attribution analysis of changes in the number of people (in millions) with vision loss by cause in China in 1990 and 2019
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prevalence of diabetic retinopathy had a positive effect on 
the increase in the number of people with blindness, and 
this factor contributed more to the increase in the number 
of people with blindness than did population ageing. The 
decline in age­specific prevalence alleviated the growth 
rate of blindness, but it was not enough to offset the effect 
of population ageing and population growth on the 
increase in the number of people with blindness.
A significant upward trend was observed in the age­
standardised prevalence of moderate vision impairment 
between 1990 and 2019 in all provinces of China 
(figure A, B). In 2019, Hong Kong, Gansu, and Hubei 
had the highest prevalence (in order of prevalence), 
followed by Guangdong, Henan, Tibet, and Jiangxi. 
The age­standardised prevalence in Shanghai, Shanxi, 
Tianjin, Ningxia, and Qinghai was relatively low. For 
severe vision impairment, age­standardised prevalence 
also rose in most provinces (figure C, D), with that 
in 2019 in Tibet, Chongqing, Guangxi, and Heilongjiang 
being the highest, and that in Shanghai being the lowest. 
The age­standardised prevalence in the eastern and 
central regions were lower than that in other regions. By 
contrast to the increase in moderate vision impairment, 
the age­standardised preva lence of blindness in all 
provinces decreased from 1990 to 2019 (figure E, F). 
Hong Kong, Shanxi, and Macao had a large decline and 
remained with the lowest prevalences in the country. The 
age­standardised preva lence of blindness in Tibet and 
Yunnan remained high.
The specific causes of vision loss in all provinces of 
China in 2019 are in the appendix (appendix 2 pp 15–20). 
More than 75% of moderate vision impairment in all 
provinces except Sichuan was caused by cataract and 
uncorrected refractive error. Hong Kong had the highest 
prevalence of moderate vision impairment caused by 
cataracts at 2711·63 per 100 000 people, which was more 
Figure: Age-standardised prevalence of moderate vision impairment, severe vision impairment, and blindness in China in 1990 and 2019
(A) Moderate vision impairment in 1990. (B) Moderate vision impairment in 2019. (C) Severe vision impairment in 1990. (D) Severe vision impairment in 2019. (E) Blindness in 1990. 
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than double that of the next highest region, Heilongjiang 
(1373·93 per 100 000 people). The provinces with the 
highest prevalence of moderate vision impairment caused 
by uncorrected refractive error were Hong Kong, Hubei, 
and Chongqing. Cataracts and uncorrected refractive 
errors accounted for more than 75% of all causes of severe 
vision impairment in most provinces, except Sichuan, 
Hainan, Inner Mongolia, and Yunnan. Jiangsu and 
Heilongjiang had the highest prevalence of severe vision 
impairment caused by cataract, whereas Chongqing, 
Jiangsu, and Hong Kong had the highest prevalence of 
severe vision impairment caused by uncorrected refractive 
error. Hubei, Heilongjiang, and Hunan had the highest 
prevalence of blindness caused by cataracts, whereas 
Inner Mongolia, Chongqing, and Tibet had the highest 
prevalence of blindness caused by uncorrected refractive 
error.
Discussion
This study clarified the prevalence, causes, and regional 
distribution of vision loss in China. Although the 
prevalence of vision loss in China was lower than the 
global average, the increase in moderate vision impair­
ment, severe vision impairment, and blindness 
from 1990 to 2019 was still concerning. During this time, 
the age­standardised prevalence of moderate vision 
impairment in China had the largest increase among the 
G20, and China was one of the few G20 countries in 
which the age­standardised prevalence of severe vision 
impairment increased. Among people older than 
70 years, about one in every five had some degree of 
vision loss. Considering the huge population of China, 
the burden of vision loss16 is heavy. Vision impairment 
and blindness remain an important public health 
problem in China that calls for attention.
From 1990 to 2019, the number of people with blindness 
in China rose by 64·35%. The age­specific prevalence of 
all blinding eye diseases other than diabetic retinopathy 
decreased, indicating that the increase in the absolute 
number of individuals with blindness was mainly due to 
population ageing and population growth. For severe 
vision impair ment, although the absolute number of 
people increased by 147·14%, the change in age­specific 
prevalence accounted for only 10·91% of the increase. 
Cause analysis showed that the pathogenic factors leading 
to moderate and severe vision impairment, including 
cataract, macular degeneration, glaucoma, and diabetic 
retinopathy, substantially increased. Analysis of the 
changes in the number of patients with vision loss 
indicated that China has made great progress in the control 
of severe eye diseases in recent years, and the prevention 
and treatment of blindness has been especially effective.6,17,18 
However, public awareness of overall visual health should 
be raised further. Future intervention efforts, including the 
establishment of research and medical institutions, the 
development of government policies, and the distribution 
of ophthalmic medical resources, should be directed at the 
prevention and treatment of severe and moderate vision 
impairment. Targeted public education prog rammes and 
corresponding health insurance and social security policies 
for visual health need to be developed. Notably, trachoma 
was the only disease with a substantial decline in the 
absolute numbers among all causes of vision impairment 
and blindness. In 2014, the prevalence of active 
trachoma in China was 0·20%,19 which was far below the 
WHO criteria20 for blind trachoma epidemic areas, 
meaning that China had successfully eliminated blinding 
trachoma.21
In 2019, the main causes of blindness in China were 
cataract, uncorrected refractive error, and glaucoma, 
whereas the main causes of severe vision impairment and 
moderate vision impairment were uncorrected refractive 
error, cataract, and macular degeneration. The ranking of 
the major causes of vision impairment and blindness 
remained the same in 2019 as in 1990. Cataract remained 
the leading cause of blindness, accounting for one­third of 
all causes. It was also the second leading cause of severe 
vision impairment and moderate vision impairment. 
Under the guidance of the project Sight First China 
Action17 and the major national public health service 
project, One Million Poor Cataract Patients Restoring 
Vision, the cataract surgery rate (CSR) in China steadily 
increased from 370 per million population in 2000 to 2205 
in 2017,22 effectively reducing the blindness rate among 
patients with cataract. However, China still fell behind the 
countries in western Europe in the treatment of cataract. 
For example, the CSR in France exceeded 10 000 in 2012.23 
Some other low­income and middle­income countries 
have also achieved better results than China, such as Iran 
with a CSR of 6328 in 2010.24 A previous study25 on 
Chaonan District, Guangdong Province, China observed 
that the leading obstacle to cataract surgery was a low level 
in patient awareness of cataract as the cause of visual 
impair ment (74·5%), followed by failure to recog nise the 
necessity of surgery (7·4%) and financial reasons (5·5%). 
Given that cataracts are more common in people 
older than 50 years, particularly in women older than 
70 years, the prevention and treatment of cataracts in older 
people should be prioritised. We call for efforts in patient 
education on basic eye care knowledge26 and the 
importance of timely treatment.
Consistent with previous global and regional studies,27 
uncorrected refractive error was the main cause of 
moderate and severe vision impairment, and the second 
leading cause of blindness. Priority should be given to 
uncorrected refractive error because it is avoidable and 
readily treatable. Refractive correction, such as wearing 
corrective glasses or refractive surgery, can effectively 
solve the issue of blurred vision caused by refractive 
error.28 Unlike in other countries,29 uncorrected refractive 
error has dropped considerably in China. Compared with 
other eye diseases, uncorrected refractive error was 
relatively less affected by population ageing, and the 
population affected are becoming younger. It should be 
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noted that myopia was the biggest burden of refractive 
error.30 Excessive eye use (ie, high­intensity and close 
working or screen time), improper reading posture (ie, 
close reading), and prolonged eye use in a dark 
environment can lead to refractive error. The popularity 
of electronic products and the reduction of outdoor 
activity time could have contri buted to the high incidence 
and low age of onset of myopia.31 Previous studies 
showed that the prevalence of myopia in children and 
adolescents increased rapidly with age, and that the 
average prevalence of myopia among children aged 
10 years in China reached 52·2% in 2013.32 The Chinese 
Government has realised the seriousness of myopia 
among children and adolescents, and formulated a plan 
to address and prevent myopia among children and 
young students in 2018.33 The implementation plan states 
that by 2030, the prevalence of myopia should be reduced 
to around 3% in children aged 6 years, less than 38% in 
primary school students, less than 60% in junior high 
school students, and less than 70% in senior high school 
students. However, the majority of parents do not have 
enough knowledge about children’s vision protection 
because of a low level of public health education, and 
visual health education in schools is also ineffective. 
Successful prevention and treatment of myopia in pre­
schools and schools relies on ample support from 
professional ophthalmology institu tions. It is also 
important to communicate the scientific evidence for the 
importance of eye health and to promote early screening 
and correction of refractive errors in adolescents.34 The 
establishment of visual health docu mentation could be 
fundamental in promoting the overall visual health of 
adolescents in China.
Diabetic retinopathy is a preventable and controllable 
blinding eye disease. It is not yet a major cause of vision 
impairment and blindness in China, but the prevalence 
has risen since 1990. The number of people with 
blindness caused by diabetic retinopathy has increased 
substantially, and the increase was attributed more to 
age­specific prevalence than to population ageing. In 
the past three decades, great changes have taken place 
in the lifestyle of Chinese people. Hypertension, hyper­
lipidaemia, and hyper glycaemia have become important 
problems affecting people’s health.35 In 2019, there 
were 116 million people with diabetes in China,36 who 
were at high risk of developing diabetic retinopathy. 
The rapid increase of systemic diseases related to 
lifestyle changes, such as metabolic diseases, will 
increase the burden of eye disease in China. Bringing 
the prevention and control of chronic eye diseases into 
the national manage ment of chronic diseases could be 
of great impor tance in reducing the burden of vision 
loss in the future.
Glaucoma ranked third in blinding eye diseases in 
China, and most of the blindness caused by glaucoma is 
irreversible. Regular ophthalmological examinations for 
high­risk groups37 and early detection and diagnosis of 
patients with glaucoma are essential for delaying the 
progression of glaucoma and reducing vision loss.
Macular degeneration was the third most common 
cause of moderate to severe vision impairment and the 
fourth most common cause of blindness in the Chinese 
population. It has also become a common cause of vision 
impairment and blindness in high­income countries.38,39 
Previous studies have found that the prevalence of 
macular degeneration is higher among older populations.40 
With the acceleration of population ageing, vision loss 
caused by age­related macular degeneration is expected to 
increase in the future.
We also studied the prevalence and causes of vision 
loss in different provinces, which was important for 
under standing the geographical distribution of various 
eye diseases and informing prevention and treatment 
stra tegies. Our research showed that although the trend 
of vision loss in most provinces was consistent with the 
overall trend in China over the past 29 years, there were 
clear differences between provinces. In 2019, Gansu, 
Hong Kong, and Hubei had high age­standardised 
prevalence of moderate vision impairment; southwest 
and southern regions (Chongqing, Guangxi, and Tibet) 
had high age­standardised prevalence of severe vision 
impairment; and southwest regions (Tibet and Yunnan) 
had high age­standardised prevalence of blindness. 
These patterns could be explained by the difference in 
local economic development, the quality of health 
services, and people’s health­related knowledge and 
health­related behaviour.41–43 Some studies in China have 
shown that the coverage of cataract surgery in Hainan 
province was high, but the quality of surgery was not 
satisfactory, which might have affected the recovery of 
postoperative visual acuity.44 In addition, the unique high 
altitude environment in Tibet could influence visual 
health.45
The analysis of the causes of vision loss in various 
provinces of China revealed the high incidence areas of 
different diseases. Chongqing, Heilongjiang, Hong Kong, 
Hubei, and Jiangsu had a high prevalence of moderate 
and severe visual impairment caused by cataract and 
uncor rected refractive error. In particular, Hong Kong 
had the highest cause­specific prevalence of all the major 
causes of moderate and severe visual impairment, indi­
cating a gap in the public visual health efforts in that 
area. In addition, uncorrected refractive error in 
Chongqing, Hubei, and Jiangsu, macular degeneration 
in Guangdong and Yunnan, and cataract in Heilongjiang 
were the main causes of vision impairment. Severe vision 
impairment caused by cataract and diabetic retinopathy 
in Chongqing and Jiangsu was also concerning. Although 
national policies on the prevention and treatment of 
blindness are well developed and implemented, there are 
still some areas with high cause­specific prevalence of 
blindness. For example, uncorrected refractive error 
in Chongqing, Inner Mongolia, and Tibet, macular 
degen eration in Jiangsu and Yunnan, glaucoma in 
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Inner Mongolia, and diabetic retinopathy in Jilin were 
particularly concerning. Therefore, prevention and 
control strategies for vision loss need to be designed 
according to local situations.
The current study is subject to all the limitations of the 
GBD studies.4,7 First, GBD 2019 estimated the models of 
vision impairment and blindness mainly through the 
available provincial­level data and previous literature in 
China.4 The absence of relevant data in some provinces 
and the failure to differentiate between urban and rural 
areas might have led to bias in the model estimates. 
Second, different clinical procedures were used to 
measure visual acuity, which might result in increased 
measure ment errors. In particular, Snellen is generally 
not the recommended way to measure visual acuity 
because its reproducibility is worse than that of the Early 
Treatment Diabetic Retinopathy Study. Third, although 
the data for vision loss were considered reasonably 
representative, estimates before 2005 might be uncertain 
due to the limited knowledge of underlying causes and 
the scarcity of the data sources before 2005. Fourth, 
many causes could lead to vision loss and it would be 
difficult to analyse all potential causes in detail, and 
therefore the interpretation of some of the results might 
not be conclusive. Moreover, some people might suffer 
from multiple diseases simultaneously, making it diffi­
cult to determine the main cause of vision loss outcomes.
In summary, vision loss is an important public health 
problem in China. Although China has made notable 
progress in reducing the age­specific prevalence of blind­
ness, the situation of moderate and severe vision impair­
ment is still severe. Public health policies related to eye 
health in China should increase their focus on the overall 
visual health of the public and on raising their awareness 
of eye care. The uneven distribution of vision loss across 
provinces requires customised inter vention strategies for 
different regions. Additionally, priority should be given 
to cataracts in older people, refractive error in adolescents 
and children, and to the rising number of patients with 
potential to develop diabetic retinopathy.
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